The Nasdaq-listed Theravance Biopharma is enhancing its Irish presence with the opening of a new corporate office in Dublin.

The Company plans to expand its Dublin employee base by hiring 30 highly-skilled professionals over the next two years in areas such as clinical development, finance, and technical operations.

Tánaiste and Minister for Business, Enterprise and Innovation Frances Fitzgerald and other IDA Ireland executives joined members of the Theravance Biopharma board and employees at the opening.

Presiden of Theravance Biopharma Ireland Dr Ann Brady said: "This important expansion within Ireland provides an opportunity to tap into the extensive biopharmaceutical talent pool within the country.

"Our Irish team looks forward to helping to build on Theravance Biopharma’s legacy of scientific expertise, advance our pipeline of potential therapies in multiple disease areas, and ultimately change the way serious diseases are treated."